BioDiscovery

El Segundo, United States Founded: 1997 • Age: 29 yrs Acquired By Bionano
Software solutions for microarray and next-generation sequencing analysis are provided.

About BioDiscovery

BioDiscovery is a Healthcare company based in El Segundo (United States) founded in 1997, and was acquired by Bionano in October 2021. Software solutions for microarray and next-generation sequencing analysis are provided. It operates in the Healthcare, Technology, and Industrial Goods & Manufacturing sectors. The company has 242 employees. Its focus areas include High Tech, Nanotechnology, Nanotools and Software Solutions. Its legal entity is BIONANO GENOMICS. Its competitors include Helix, Benchling and BioAge Labs; 3 of its 3 listed competitors have raised funding.

Company details

BioDiscovery was founded in 1997 and is located in El Segundo, United States. Software tools are developed for analyzing microarray and next-generation sequencing data in the genomics sector. The flagship product, NxClinical, is employed for genomic sequencing analysis and variant detection by healthcare providers. Additional resources, including Nexus Copy Number, Nexus Expression, TCGA Premier, NexusDB, and ImaGene, are supplied to support bioinformatics research operations.

  • Headquarters El Segundo, United States
  • Employees 242
  • Stage Acquired
  • Sectors
    Healthcare
    Technology Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website biodiscovery.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by Bionano (Oct 2021)
  • Legal Name Bionano Genomics
Key Metrics
  • Latest Funding Round
    $156.81K (USD), Grant

    Jun 2014

  • Investors
    HHS

    & 1 more

  • Employee Count
    242
  • Acquired by
    Bionano

    (Oct 2021)

Funding Insights of BioDiscovery

  • Total Rounds 2
  • Last Round Grant β€” $156,809
  • First Round $1M

    (Aug 2010)

  • Investors Count 1

All 2 funding rounds of BioDiscovery with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2014$156,809Grant––
Aug 2010$1MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in BioDiscovery

BioDiscovery has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Bionano.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Provider of genome analysis solutions to researchers and clinicians
2002bionano.comSan Diego, United States
Premium access

Investor details for BioDiscovery

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of BioDiscovery

4 dated milestones of BioDiscovery across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioDiscovery is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Grant, of $157K.
  4. Exit Acquired by Bionano.

Competitors of BioDiscovery

BioDiscovery has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and BioAge Labs.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
helix.com2015San Francisco, United States$435M
Genomic database for clinical research is provided.
benchling.com2012San Francisco, United States$411.9M640
Cloud-based bioinformatics platform is offered for biotech research.
bioagelabs.com2015Vallejo, United States$293.9M43
Bioinformatics platform is provided for biomarkers and drug discovery.
Premium access

Detailed competitors of BioDiscovery

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioDiscovery

The website of BioDiscovery (biodiscovery.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▲ 508.7% vs previous month

Similar websites

Websites whose visitors overlap most with BioDiscovery. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ingenuity.com
100%
24.3K#619,156View details
jbrowse.org
jbrowse.org
89%
#3,350,815–
biobind.com
biobind.com
86%
–
bioxing.com
86%
View details
healthdiscoverycorp.com
86%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for BioDiscovery

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as BioDiscovery (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biodiscovery

Premium access

Complete news archive for BioDiscovery

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioDiscovery

BioDiscovery was founded in 1997 and raised its 1st funding round 13 years after it was founded.

BioDiscovery is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.

BioDiscovery has 242 employees.

BioDiscovery was founded in 1997 and is located in El Segundo, United States. Software tools are developed for analyzing microarray and next-generation sequencing data in the genomics sector. The flagship product, NxClinical, is employed for genomic sequencing analysis and variant detection by healthcare providers. Additional resources, including Nexus Copy Number, Nexus Expression, TCGA Premier, NexusDB, and ImaGene, are supplied to support bioinformatics research operations.

BioDiscovery's top competitors include Helix, Benchling and BioAge Labs.

BioDiscovery has 2 investors. Key investors include HHS, and Bionano.

BioDiscovery operates through Bionano Genomics.

Yes. BioDiscovery was acquired by Bionano in October 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available